Indonesia vs Japan: Treatment success rate for patients treated for MDR-TB
Indonesia
59.0%
in 2022
Japan
59.0%
in 2022
Indonesia rank
125th
Japan rank
125th
Treatment success rate for patients treated for MDR-TB over time
- Indonesia
- Japan
How they compare
Indonesia currently reports 59.0% against 59.0% in Japan, a difference of 0.0%.
Across all 7 years both countries report, Japan has been ahead every year.
Indonesia ranks 125th and Japan ranks 125th of 163 countries.
Japan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Indonesia | Japan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 46.8% | 57.0% | 10.2% | Japan |
| 2020s | 56.0% | 64.0% | 8.0% | Japan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Indonesia or Japan?
- Indonesia, at 59.0% against 59.0% in Japan as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Indonesia and Japan?
- 0.0%, with Indonesia ahead.
- How many years of comparable data are there for Indonesia and Japan?
- 7 years are reported by both, from 2016 to 2022.
- How do Indonesia and Japan rank globally for treatment success rate for patients treated for mdr-tb?
- Indonesia ranks 125th and Japan ranks 125th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.